Pharmaceutical and life sciences auditing firm, STEM Healthcare, part of Ashfield Advisory, has appointed Dermot Kenny as CEO.
Kenny has experience in the pharmaceutical industry spanning 25 years. His most recent role was leading Novartis’ Global Clinical Technology and Innovation team.
Throughout his career, Kenny has led global teams, built large-scale custom client solutions, implemented various clinical development platforms and driven organisational transformation.
At STEM Healthcare, he will be responsible for “driving growth, diversifying the company’s offering and expanding its geographic reach and global presence”.
The company aims to help its clients evaluate and improve field team performance using a benchmark database that includes more than 500,000 in-field observations completed across 59 countries.
Kenny said: “It’s a privilege to join STEM Healthcare at such a pivotal time for the industry and in the company’s journey. STEM Healthcare has an exceptional reputation and works with many of the leading companies in the pharma and biotech sectors to help enhance their performance at a time when the market is becoming increasingly complex and competitive.
“Our success has been built on the quality of STEM Healthcare’s people, their credibility and ability to engage productively with both local and global functions. I’m very excited to be leading the next phase of STEM Healthcare’s growth.”
